- Report
- August 2022
- 100 Pages
Global
From €4213EUR$4,750USD£3,654GBP
- Report
- May 2022
- 163 Pages
Global
From €3193EUR$3,600USD£2,769GBP
- Report
- March 2022
- 180 Pages
Global
From €3193EUR$3,600USD£2,769GBP
- Report
- June 2025
- 250 Pages
India
From €2474EUR$2,789USD£2,146GBP
- Report
- June 2025
- 250 Pages
Japan
From €2474EUR$2,789USD£2,146GBP
- Report
- May 2024
- 292 Pages
Global
From €4430EUR$4,995USD£3,843GBP
- Report
- January 2022
- 278 Pages
Global
From €3770EUR$4,250USD£3,270GBP
- Report
- November 2021
- 159 Pages
Global
From €3770EUR$4,250USD£3,270GBP
- Report
- July 2023
- 102 Pages
Global
From €3500EUR$4,227USD£3,142GBP
- Report
- September 2025
- 50 Pages
Global
From €2350EUR$2,650USD£2,039GBP
- Report
- September 2025
- 50 Pages
Global
From €2350EUR$2,650USD£2,039GBP
- Report
- September 2025
- 50 Pages
Global
From €2350EUR$2,650USD£2,039GBP
- Report
- November 2021
- 600 Pages
Global
From €3548EUR$4,000USD£3,077GBP

Morphine is an analgesic drug used to treat moderate to severe pain. It is a member of the opioid family, and is derived from the opium poppy plant. Morphine is available in a variety of forms, including tablets, capsules, syrups, and injectable solutions. Morphine is often used in the treatment of cancer pain, post-operative pain, and chronic pain. It is also used to treat acute pain, such as that caused by a heart attack or stroke. Morphine is generally considered to be a safe and effective analgesic, but it can cause side effects such as nausea, vomiting, constipation, and drowsiness.
Morphine is available in both generic and brand-name formulations. Some of the major companies in the market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more